The common findings in the three strains, as is the case for iNos expression, strongly support a consistent association of iNOS with depression, which renders it a candidate target in new therapeutic approaches for mood disorders as suggested by other authors (Wang et al., 2008; Montezuma et al., 2012; Peng et al., 2012). The gene discussed is NOS2; the disease is depressive symptom measurement.